ℹ️
🇬🇧
Search
Search for publications relevant for "vedolizumab"
vedolizumab
Publication
Class
Person
Publication
Programmes
Export current view
publication
Vedolizumab, its pharmacological profile and therapeutic use
2018 |
Faculty of Medicine in Hradec Králové
publication
Vedolizumab in the treatment of inflammatory bowel diseases
2016 |
First Faculty of Medicine
publication
Vedolizumab in the therapy of Crohn's disease
2015 |
First Faculty of Medicine
publication
Vedolizumab in the therapy of ulcerative colitis patients
2015 |
First Faculty of Medicine
publication
Vedolizumab for the treatment of Crohn's disease and ulcerative colitis
2015 |
First Faculty of Medicine
publication
Early vedolizumab trough levels are not associated with short-term response in patients with inflammatory bowel disease
2019 |
First Faculty of Medicine, Central Library of Charles University
publication
First experience of vedolizumab in paediatric IBD patients
+1
2019 |
Second Faculty of Medicine
publication
Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease - a multicentre retrospective-prospective observational study
2022 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
Vedolizumab
2017 |
First Faculty of Medicine
publication
Vedolizumab as induction and maintenance therapy for Crohn's disease
2013 |
First Faculty of Medicine
publication
Biological therapy of ulcerative colitis during pregnancy
2023 |
Faculty of Medicine in Pilsen
publication
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study
2021 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Vedolizumab vs. Ustekinumab as second-line therapy in Crohn's disease in clinical practice
2019 |
First Faculty of Medicine
publication
Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study
2022 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
2017 |
Second Faculty of Medicine
publication
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
2017 |
First Faculty of Medicine